Single-Agent Gemcitabine for Biliary Tract Cancers

Publisher： Karger

E-ISSN： 1423-0232|70|5|358-365

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.5, 2007-01, pp. : 358-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

By  

Oncology, Vol. 60, Iss. 4, 2001-06 ,pp. : 303-307

Karger

Access to resources Recommend Favorite

Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 311-315

Karger

Access to resources Recommend Favorite

Chemotherapy with Gemcitabine in Advanced Biliary Tract Carcinoma

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 70-78

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy and Histological Stratification of Biliary Tract Cancers

By  

Oncology, Vol. 82, Iss. 6, 2012-06 ,pp. : 352-353

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine in Previously Untreated Elderly Patients with Advanced Bladder Carcinoma: Response to Treatment and Correlation with the Comprehensive Geriatric

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 27-32

Karger

Access to resources Recommend Favorite